AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Glyphmet M2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Biotics Lab Life Services Private Limited

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glyphmet M2 Tablet SR

Metformin-glimepiride extended-release tablets are categorized as antidiabetic medications. This dual-drug formulation treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your glycemic response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can lead to hyperglycemia and potentially serious complications including renal impairment, vision loss, neuropathy, and limb amputation. This medication is one component of a comprehensive diabetes management plan incorporating a balanced diet, physical activity, and weight management as directed by your doctor. Lifestyle modifications are key to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, manifested by symptoms such as sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic effect. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your doctor before initiating treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended.

Primary Ingredients of Glyphmet M2 Tablet SR

No text provided. Please provide the text you want me to rephrase.

Uses of Glyphmet M2 Tablet SR

Managing type 2 diabetes

Major Benefits of Glyphmet M2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glyphmet M2 Tablet SR. Ingest the tablet whole; do not chew, crush, or divide it. Always take this medication with food.

Common Side effects of Glyphmet M2 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glyphmet M2 Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glyphmet M2 Tablet SR should be administered with a meal.

How Glyphmet M2 Tablet SR works:

Glymet M2 SR tablets combine glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glyphmet M2 Tablet SR and alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glyphmet M2 Tablet SR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glyphmet M2 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glyphmet M2 Tablet SR, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult your physician. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glyphmet M2 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. A reduced initial dose is typically prescribed for individuals with mild to moderate liver disease; however, its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Glyphmet M2 Tablet SR :

Should you forget a Glyphmet M2 Tablet SR dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid doubling the prescribed amount.

Facts to Know About Glyphmet M2 Tablet SR

LabelValue
Potential for Dependence None.
Medication Classification Medication for diabetes

FAQs on Glyphmet M2 Tablet SR

Retain this medication within its original, securely sealed container or packaging. Follow the storage guidelines specified on the packaging or label. Discard any remaining medication. Ensure its inaccessibility to children, pets, and others.
Glyphmet M2 Tablet SR use carries a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is more likely in individuals with kidney impairment, the elderly, or those consuming significant alcohol. Symptoms can manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, vomiting, abdominal discomfort, or bradycardia. Should these symptoms appear, discontinue Glyphmet M2 Tablet SR and seek immediate medical attention.
Glyciphage M2 SR tablets contain glimepiride and metformin, working together to manage type 2 diabetes. This medication helps regulate blood sugar in adults when combined with a healthy diet and exercise regimen. Glimepiride stimulates insulin release from the pancreas, thereby reducing blood glucose. Metformin decreases liver glucose production and enhances insulin responsiveness. This formulation is unsuitable for managing type 1 diabetes.
Taking Glyphmet M2 Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), changes in taste perception, nausea, abdominal discomfort, diarrhea, and headaches. Less frequent, but potentially serious, adverse reactions include lactic acidosis. Prolonged use might also result in a Vitamin B12 deficiency.
Prolonged Glyphmet M2 Tablet SR use can indeed lead to Vitamin B12 deficiency by hindering its absorption in the gastrointestinal tract. This deficiency, if left unaddressed, may result in anemia, neurological complications including peripheral neuropathy (manifesting as tingling, numbness in extremities, and weakness), urinary dysfunction, cognitive changes, and ataxia. Preventive strategies proposed by some studies involve supplemental Vitamin B12 intake at least annually.
Indeed, Glyphmet M2 Tablet SR can induce hypoglycemia—a condition characterized by low blood glucose. Manifestations of this include nausea, headache, irritability, hunger pangs, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, regular blood glucose monitoring is crucial. Carrying a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice, is advisable.
Combining Glyphmet M2 Tablet SR and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and an elevated risk of lactic acidosis.
Glyphmet M2 Tablet SR
64
MRP 78
17% off